Delivery Order SPE2DB24D1021-SPE2DB25FEXGS
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 ml pen medication with a ceiling value of $1,121.31. The contract was awarded on May 20, 2025, with an ultimate completion date of May 21, 2025, and utilizes firm fixed price terms. This delivery order represents a non-set-aside, competitively awarded transaction and is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 3 mg/0.5 ml pen injections, valued at $1,641.36, with an ultimate completion date of July 22, 2025. The contract was competitively awarded on July 21, 2025, using firm fixed pricing with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a single pharmaceutical procurement under...
- AmerisourceBergen Drug Corp was awarded a firm fixed price delivery order valued at $1,788.24 by the Defense Logistics Agency (DLA) on October 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens (0.5 mL). The contract, which represents a non-competitive set-aside delivery, is scheduled for completion by October 31, 2025, with performance based in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,878.61 by the Defense Logistics Agency (DLA) on September 18, 2025, with a completion date of September 19, 2025. The contract covers the supply of Trulicity 1.5 mg/0.5 mL pen injectable medication, a diabetes treatment. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,419.13 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price delivery order, with an ultimate completion date of June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The award carries no set-aside designation and reflects...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,717.94 delivery order on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections, a diabetes medication. This firm fixed-price contract, with an ultimate completion date of August 18, 2025, represents a child delivery order under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,356.84 by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This contract represents a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order falls under...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXGSDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,702.70 by the Defense Logistics Agency (DLA) on June 2, 2025, with an ultimate completion date of June 3, 2025. The delivery order is for Trulicity 1.5 mg/0.5 ml pen injectables and was issued under a firm fixed-price, non-set-aside competitive contract. This child delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The DLA Medical Supply Chain relies on strategic vendor partnerships like AmerisourceBergen to supply essential pharmaceuticals and medical commodities to support military and veteran healthcare systems. Trulicity, a diabetes management medication, represents the type of specialized therapeutic pharmaceutical included in the company's extensive federal contract portfolio. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its significant prime vendor status with DLA Troop Support, positions the company as a critical supplier within the Defense Health Agency's pharmaceutical distribution network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 6/2/25 |